Leukocyte telomere length is linked to vascular risk factors not to Alzheimer’s disease in the VITA study
The DOI matches its Crossref record; 47 of the 48 references it cites were found in a registry or an index.
Abstract
Association of telomere shortening with overall dementia or Alzheimer's disease is described controversially and the pathophysiologic relevance is unclear. Whether patients, suffering from pure probable Alzheimer's disease or pure vascular dementia, have shorter leukocyte telomeres than cognitively healthy controls was determined. Leukocyte telomere lengths (LTLs) of 597 participants of the VITA study (longitudinal community-based age-cohort [mean 75.7 (±0.45) years] study: 243 male; 578 non-demented at baseline) were compared with different aspects of cognition, risk factors of dementia and survival. LTLs of 264 persons cognitively healthy at baseline (mild cognitive impaired excluded) and all follow-ups (mean = 5643 bp, SD = 736) did not show any difference to LTLs of 43 incident pure possible (mean = 5548 bp; SD = 666) or 34 incident pure probable Alzheimer's diseases (mean = 5712 bp; SD = 695; post hoc Dunnett test: MD = -95; SE = 119; p = 0.67 and MD =+68.3; SE = 132; p = 0.84, res.). 264 stably cognitively healthy showed a trend to longer telomeres than 6 incident vascular dementias (mean = 5643 bp, SD = 736 vs mean = 5101 bp, SD = 510; t test: T = 1.8; df = 268; p = 0.07). Males (n = 243; mean = 5470 bp; SD = 684) had significantly shorter telomeres than females (n = 354; mean = 5686 bp; SD = 714; t test: T = -3.7; df = 595; p = 0.0001) and died significantly earlier (113.7 vs 130.1 months: Log Rank Chi square = 12.2; p = 0.0001). Shorter telomeres were associated with…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“a large community-based longitudinal study reported no difference in the telomere length between incident pure AD patients and cognitively healthy individuals [249].”
From Ageing, Cellular Senescence and Neurodegenerative Disease (2018) · cites this paper as [249]
Citations
Cites
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Heart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association
Tsao, C. W., Aday, A. W., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Beaton, A. Z., Boehme, A. K., Buxton, A. E., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001123 · Cited by 8,300
Mild cognitive impairment as a diagnostic entity
Petersen, R. C. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01388.x · Cited by 7,864 · cited 1×
“487 (190 male) out of 499 were non-demented at BL including 115 (38 male) mild cognitive impaired (MCI) according to Petersen (2004) and 372 (152 male) cognitively healthy.”
MethodHeart Disease and Stroke Statistics—2012 Update: A Report From the American Heart Association
Writing Group Members, Roger, V. L., Go, A. S., Lloyd-Jones, D. M., Benjamin, E. J., Berry, J. D., Borden, W. B., Bravata, D. M., Dai, S., Ford, E. S., et al. (2012) · Circulation · doi:10.1161/cir.0b013e31823ac046 · Cited by 7,333 · cited 3×
“For women, comparable rates occur approximately 10 years later in life (Roger et al. 2012).”
BackgroundRomán, G. C., Tatemichi, T. K., Erkinjuntti, T., Cummings, J. L., Masdeu, J. C., Garcia, J. H., Amaducci, L., Orgogozo, J.-M., Brun, A., Hofman, A., et al. (1993) · Neurology · doi:10.1212/wnl.43.2.250 · Cited by 4,921
McKeith, I. G., Galasko, D., Kosaka, K., Perry, E. K., Dickson, D. W., Hansen, L. A., Salmon, D. P., Lowe, J., Mirra, S. S., Byrne, E. J., et al. (1996) · Neurology · doi:10.1212/wnl.47.5.1113 · Cited by 3,960 · cited 1×
“LBD was diagnosed according to the Newcastle criteria (McKeith et al. 1996).”
MethodOxidative stress shortens telomeres
von Zglinicki, T. (2002) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(02)02110-2 · Cited by 2,524 · cited 3×
“LTL shortening reflects the lifelong accumulation of detrimental inflammation and oxidative stress (Boccardi et al. 2015; Gebreab et al. 2017; Von Zglinicki 2002).”
BackgroundAssociation between telomere length in blood and mortality in people aged 60 years or older
Cawthon, R. M., Smith, K. R., O'Brien, E., Sivatchenko, A., & Kerber, R. A. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12384-7 · Cited by 1,761 · cited 1×
“Significantly shorter LTL in males and shorter survival of males compared to females, as found in the VITA study, are well-described phenomena (Cawthon et al. 2003; Fitzpatrick et al. 2011; Honig et al. 2012).”
ResultBlackburn, E. H., Epel, E. S., & Lin, J. (2015) · Science · doi:10.1126/science.aab3389 · Cited by 1,596 · cited 3×
“Telomeres of adult somatic cells lacking the repair enzyme telomerase shorten during each replication cycle until cellular senescence, while telomerase restores telomere length in various tissue stem cells (Blackburn et al. 2015).”
BackgroundTelomere length measurement by a novel monochrome multiplex quantitative PCR method
Cawthon, R. M. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn1027 · Cited by 1,410 · cited 1×
“DNA measurements of LTL according to Cawthon (2009) are described in detail in the Online Resources (Tables S1 and S2, pp 2–4).”
Method
Cited by
Ageing, Cellular Senescence and Neurodegenerative Disease
Kritsilis, M., V. Rizou, S., Koutsoudaki, P. N., Evangelou, K., Gorgoulis, V. G., & Papadopoulos, D. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19102937 · Cited by 448
“However, a large community-based longitudinal study reported no difference in the telomere length between incident pure AD patients and cognitively healthy individuals [249].”
BackgroundCellular Senescence in Neurodegenerative Diseases
Martínez-Cué, C., & Rueda, N. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00016 · Cited by 281
Aging, Cellular Senescence, and Alzheimer’s Disease
Liu, R.-M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23041989 · Cited by 267
“Numerous studies have shown that telomere shortening is associated with aging and aging-related diseases, including AD [59–65], although noassociation results have also been reported [66,67].”
BackgroundInnes, K. E., Selfe, T. K., Brundage, K., Montgomery, C., Wen, S., Kandati, S., Bowles, H., Khalsa, D. S., & Huysmans, Z. (2018) · Journal of Alzheimer’s Disease · doi:10.3233/jad-180164 · Cited by 105
Senescence: A DNA damage response and its role in aging and Neurodegenerative Diseases
Shreeya, T., Ansari, M. S., Kumar, P., Saifi, M., Shati, A. A., Alfaifi, M. Y., & Elbehairi, S. E. I. (2024) · Frontiers in Aging · doi:10.3389/fragi.2023.1292053 · Cited by 83
Metadata
- Authors
- Hinterberger, M., Fischer, P., Huber, K., Krugluger, W., & Zehetmayer, S.
- Affiliations
- Ludwig Boltzmann Institute for Age Research (AT)
- Johannes Kepler University of Linz (AT)
- Corresponding author
- Hinterberger, Margareta
- Venue
- Journal of Neural Transmission
- Published
- 2017-04-09
- Volume
- 124
- Issue
- 7
- Pages
- 809-819
- ISSN
- 0300-9564 (ISSN-L)
- 1435-1463
- OpenAlex
- W2604147665
- Cited by
- 28
- References
- 48
- Citations by year
- 2025: 3 · 2024: 6 · 2023: 3 · 2022: 4 · 2021: 3 · 2020: 2 · 2019: 4 · 2018: 3
- FWCI
- 2.02
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Neural Transmission (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Pfizer Austria (unrestricted grant)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Cognitive Abilities and Testing
- Keywords
- leukocyte telomere length, telomere shortening, Alzheimer's disease, vascular dementia, vascular risk factors, dementia, sex differences, mortality, cognitive function, aging
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Female, Humans, Leukocytes, Longitudinal Studies, Male, Risk Factors, Dementia, Vascular, Cohort Studies, Telomere Shortening
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Leukocyte telomere length is linked to vascular risk factors not to Alzheimer’s disease in the VITA study. https://app.cochat.ai/papers/10.1007/s00702-017-1721-z
- The paper
- Hinterberger, M., Fischer, P., Huber, K., Krugluger, W., & Zehetmayer, S. (2017). Leukocyte telomere length is linked to vascular risk factors not to Alzheimer’s disease in the VITA study. Journal of Neural Transmission. https://doi.org/10.1007/s00702-017-1721-z
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.